Certara, Inc. (NASDAQ:CERT) Holdings Increased by Motley Fool Asset Management LLC

Motley Fool Asset Management LLC grew its stake in shares of Certara, Inc. (NASDAQ:CERT) by 8.7% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 49,895 shares of the company’s stock after buying an additional 4,005 shares during the quarter. Motley Fool Asset Management LLC’s holdings in Certara were worth $878,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. State of New Jersey Common Pension Fund D raised its holdings in shares of Certara by 11.1% during the fourth quarter. State of New Jersey Common Pension Fund D now owns 168,633 shares of the company’s stock valued at $2,966,000 after acquiring an additional 16,848 shares during the period. New York State Common Retirement Fund grew its position in Certara by 6.8% during the fourth quarter. New York State Common Retirement Fund now owns 239,853 shares of the company’s stock valued at $4,219,000 after purchasing an additional 15,277 shares in the last quarter. Louisiana State Employees Retirement System purchased a new position in Certara during the fourth quarter valued at approximately $943,000. Advisors Preferred LLC purchased a new position in Certara during the fourth quarter valued at approximately $2,419,000. Finally, Trust Point Inc. purchased a new position in Certara during the fourth quarter valued at approximately $320,000. 73.96% of the stock is currently owned by institutional investors.

Insider Transactions at Certara

In other news, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the sale, the insider now owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In other news, insider Patrick F. Smith sold 14,427 shares of the company’s stock in a transaction dated Tuesday, April 2nd. The shares were sold at an average price of $16.85, for a total value of $243,094.95. Following the sale, the insider now owns 50,091 shares of the company’s stock, valued at approximately $844,033.35. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Also, SVP Richard M. Traynor sold 3,000 shares of the company’s stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $18.00, for a total transaction of $54,000.00. Following the completion of the sale, the senior vice president now directly owns 173,524 shares in the company, valued at approximately $3,123,432. The disclosure for this sale can be found here. In the last quarter, insiders have sold 23,427 shares of company stock valued at $405,095. 2.60% of the stock is owned by insiders.

Certara Stock Performance

NASDAQ:CERT traded up $0.27 during trading hours on Friday, hitting $16.57. 321,643 shares of the company traded hands, compared to its average volume of 533,272. The stock has a market capitalization of $2.65 billion, a price-to-earnings ratio of -47.34, a P/E/G ratio of 1.70 and a beta of 1.63. Certara, Inc. has a twelve month low of $11.81 and a twelve month high of $24.64. The firm has a 50-day moving average of $17.69 and a 200 day moving average of $16.24. The company has a current ratio of 2.62, a quick ratio of 2.62 and a debt-to-equity ratio of 0.28.

Certara (NASDAQ:CERT) last announced its quarterly earnings data on Thursday, February 29th. The company reported $0.05 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.09 by ($0.04). Certara had a negative net margin of 15.62% and a positive return on equity of 4.33%. The business had revenue of $88.01 million during the quarter, compared to analyst estimates of $86.80 million. On average, analysts forecast that Certara, Inc. will post 0.29 EPS for the current year.

Analyst Upgrades and Downgrades

CERT has been the subject of several recent research reports. KeyCorp raised shares of Certara from a “sector weight” rating to an “overweight” rating and set a $23.00 target price for the company in a research report on Wednesday, April 10th. Barclays boosted their price objective on shares of Certara from $16.00 to $18.00 and gave the stock an “equal weight” rating in a research note on Thursday, January 25th. Jefferies Financial Group boosted their price objective on shares of Certara from $14.00 to $15.50 and gave the stock a “hold” rating in a research note on Friday, March 1st. UBS Group boosted their price objective on shares of Certara from $17.00 to $20.00 and gave the stock a “neutral” rating in a research note on Friday, March 1st. Finally, SVB Leerink initiated coverage on shares of Certara in a research note on Monday, February 26th. They issued a “market perform” rating and a $19.00 price objective for the company. Seven research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus price target of $20.06.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.